# Zhejiang Huahai Pharmaceutical – FDA Inspection, May 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical/b372541c-3043-4904-ac57-0ba2c3b72570
Source feed: FDA_Inspections

> FDA inspection 1012805 of Zhejiang Huahai Pharmaceutical, May 19, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012805
- Company Name: Zhejiang Huahai Pharmaceutical
- Inspection Date: 2017-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1255905 - 2024-11-20](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical/07e8ffd9-9d11-4463-b53d-85f4ca55830c)
- FDA Inspection 1150702 - 2021-07-29
- [FDA Inspection 1062283 - 2018-08-03](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical/18f98fae-eaca-4740-bb4c-d005f04e2a6b)
- FDA Inspection 886530 - 2014-05-23
- FDA Inspection 712157 - 2010-09-08

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)

Company: https://www.keypedia.com/companies/zhejiang-huahai-pharmaceutical/7742a83d-0a0c-4aed-9039-0b8b928ce70f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c